Cardioprotective role of SMYD2 in right ventricular hypertrophy
17 February 2026
Presented at PVRI 2026 Congress by Ralph Schermuly, Justus-Liebig-Universität Gießen
Summary
Right ventricular hypertrophy involves the role of methyl transferases, especially SM2, in heart function. It examines how pressure affects right ventricular performance, the significance of angiogenesis, and the impact of hypoxia on cardiac signaling. The content also reviews experimental models for studying right heart hypertrophy and discusses the relevance of these findings to cancer research and adaptive scenarios like pregnancy or exercise-induced hypertrophy.
Generated with AI, edited by PVRI
Our speaker
Ralph Schermuly, Justus-Liebig-Universität Gießen